TRMB Stock Analysis: Trimble | NASDAQ
Scientific & Technical Instruments | NASDAQ, USA | Market Cap: 13.417m USD | 12M Return: -30.4% | US8962391004 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 150M
EPS Trend: 91.8%
Qual. Beats: 6
Rev. Trend: -36.5%
Qual. Beats: 7
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Trimble Inc. (NASDAQ: TRMB) is a U.S.-based technology provider that develops software, hardware, and positioning solutions connecting office and field workflows across the architecture, engineering, construction, and transportation/logistics industries. Headquartered in Westminster, Colorado, and founded in 1978, the company operates globally and sells its offerings both directly to end users and through third-party software integrations.
The business is organized around software platforms (BIM, estimating, project management, and 3D design tools), machine guidance systems for heavy equipment (excavators, dozers, graders, pavers), asset and worker monitoring solutions, and a portfolio of satellite-based positioning services under the RTX brand. It also provides transportation and logistics software for shippers, carriers, and retailers, including carrier TMS, the Transporeon freight platform, and MAPS truck-routing solutions.
As a large-cap member of the GICS Information Technology sector (Electronic Equipment & Instruments sub-industry), Trimbles model combines subscription/SaaS-style software with hardware-anchored geospatial technology and recurring positioning services, creating a mix of upfront equipment sales plus ongoing software and service revenue tied to customer lifecycle usage.
- Construction software ARR growth accelerates industry digital transformation
- Transporeon integration drives double-digit Transportation segment revenue growth
- Subscription mix expansion lifts blended gross margins portfolio-wide
| Net Income: -104.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -1.43 > 1.0 |
| NWC/Revenue: -1.73% < 20% (prev -2.52%; Δ 0.80% < -1%) |
| CFO/TA 0.06 > 3% & CFO 505.3m > Net Income -104.7m |
| Net Debt (1.37b) to EBITDA (841.0m): 1.63 < 3 |
| Current Ratio: 0.95 > 1.5 & < 3 |
| Outstanding Shares: last quarter (233.0m) vs 12m ago -2.75% < -2% |
| Gross Margin: 68.36% > 18% (prev 65.84%; Δ 2.52% > 0.5%) |
| Asset Turnover: 42.89% > 50% (prev 38.11%; Δ 4.78% > 0%) |
| Interest Coverage Ratio: 8.28 > 6 (EBIT TTM 661.1m / Interest Expense TTM 79.8m) |
| A: -0.01 (Total Current Assets 1.34b - Total Current Liabilities 1.41b) / Total Assets 8.54b |
| B: 0.32 (Retained Earnings 2.70b / Total Assets 8.54b) |
| C: 0.07 (EBIT TTM 661.1m / Avg Total Assets 8.82b) |
| D: 1.49 (Book Value of Equity 5.11b / Total Liabilities 3.43b) |
| Altman-Z'' = 3.05 = A |
| DSRI: 1.02 (Receivables 598.1m/539.5m, Revenue 3.78b/3.47b) |
| GMI: 0.96 (GM 65.84% / 68.36%) |
| AQI: 0.98 (AQ_t 0.82 / AQ_t-1 0.84) |
| SGI: 1.09 (Revenue 3.78b / 3.47b) |
| TATA: -0.07 (NI -104.7m - CFO 505.3m) / TA 8.54b) |
| Beneish M = -3.00 (Cap -4..+1) = AA |
As of August 17, 2026, the stock is trading at USD 57.60 with a total of 3,995,945 shares traded. Over the past week, the price has changed by -3.21%, over one month by +7.16%, over three months by +4.69% and over the past year by -30.43%.
Current recommended Stop Loss: 52.60 (which is 8.7% or 2.2 ATR below the current price).
Trimble has received a consensus analysts rating of 4.42. Therefore, it is recommended to buy TRMB.
- StrongBuy: 6
- Buy: 5
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 81.3 | 41.1% |
P/E Forward = 16.3132
P/S = 3.5468
P/B = 2.4166
P/EG = 1.6301
Revenue TTM = 3.78b USD
EBIT TTM = 661.1m USD
EBITDA TTM = 841.0m USD
Long Term Debt = 1.39b USD (from longTermDebt, last fiscal year)
Short Term Debt = 16.4m USD (from shortTermDebt, last quarter)
Debt = 1.58b USD (from shortLongTermDebtTotal, last quarter) + Leases 123.4m
Net Debt = 1.37b USD (calculated: Debt 1.58b - CCE 214.4m)
Enterprise Value = 14.8b USD (13.4b + Debt 1.58b - CCE 214.4m)
Interest Coverage Ratio = 8.28 (Ebit TTM 661.1m / Interest Expense TTM 79.8m)
EV/FCF = 58.49x (Enterprise Value 14.8b / FCF TTM 252.8m)
FCF Yield = 1.71% (FCF TTM 252.8m / Enterprise Value 14.8b)
FCF Margin = 6.68% (FCF TTM 252.8m / Revenue TTM 3.78b)
Net Margin = -2.77% (Net Income TTM -104.7m / Revenue TTM 3.78b)
Gross Margin = 68.36% ((Revenue TTM 3.78b - Cost of Revenue TTM 1.20b) / Revenue TTM)
Gross Margin QoQ = 69.43% (prev 65.88%)
Tobins Q-Ratio = 1.73 (Enterprise Value 14.8b / Total Assets 8.54b)
Interest Expense / Debt = 5.04% (Interest Expense 79.8m / Debt 1.58b)
Taxrate = 16.76% (85.4m / 509.4m)
NOPAT = 550.3m (EBIT 661.1m * (1 - 16.76%))
Current Ratio = 0.95 (Total Current Assets 1.34b / Total Current Liabilities 1.41b)
Debt / Equity = 0.31 (Debt 1.58b / totalStockholderEquity, last quarter 5.11b)
Debt / EBITDA = 1.63 (Net Debt 1.37b / EBITDA 841.0m)
Debt / FCF = 5.41 (Net Debt 1.37b / FCF TTM 252.8m)
Total Stockholder Equity = 5.59b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.19% (Net Income -104.7m / Total Assets 8.54b)
RoE = -1.87% (Net Income TTM -104.7m / Total Stockholder Equity 5.59b)
RoCE = 9.46% (EBIT 661.1m / Capital Employed (Equity 5.59b + L.T.Debt 1.39b))
RoIC = 7.91% (NOPAT 550.3m / Invested Capital 6.96b)
WACC = 9.25% (E(13.4b)/V(15.0b) * Re(9.85%) + D(1.58b)/V(15.0b) * Rd(5.04%) * (1-Tc(0.17)))
Discount Rate = 9.85% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -92.91 | Cagr: -2.63%
[DCF] Terminal Value 69.79% ; FCFF base≈311.4m ; Y1≈273.1m ; Y5≈220.6m
[DCF] Fair Price = 7.35 (EV 3.08b - Net Debt 1.37b = Equity 1.71b / Shares 233.2m; r=9.25% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 91.79 | EPS CAGR: 8.26% | SUE: 0.85 | # QB: 6
Revenue Correlation: -36.54 | Revenue CAGR: -1.45% | SUE: 1.61 | # QB: 7
EPS current Quarter (2026-09-30): EPS=0.87 | Chg30d=+0.00% | Revisions=-46% | Analysts=12
EPS current Year (2026-12-31): EPS=3.59 | Chg30d=+0.09% | Revisions=+25% | GrowthEPS=+14.7% | GrowthRev=+8.5%
EPS next Year (2027-12-31): EPS=4.08 | Chg30d=+0.08% | Revisions=+25% | GrowthEPS=+13.6% | GrowthRev=+8.2%
[Analyst] Revisions Ratio: -27% (up=4, down=8)